February 3, 2017 · STOCK Act disclosure
Representative K. Michael Conaway (Republican-TX) bought Innate Immunotherapeutics, a stock transaction, valued at $1,001 - $15,000. The trade took place on February 3, 2017 and was disclosed on March 2, 2017 (owner: Joint). Members of Congress must report such transactions within 45 days under the STOCK Act.